April 23, 2019 Analysis of Medication Abortion Risk and the FDA report “Mifepristone U.S. Post-Marketing Adverse Events Summary through 12/31/2018”
December 20, 2017 Assessing barriers to medication abortion among California’s public university students
December 18, 2017 Evaluating University of California (UC) and California State University (CSU) capacity to provide medication abortion
August 29, 2016 Impact of Ohio’s law mandating use of the FDA-approved protocol for medication abortion
